These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 7209877)

  • 1. Thrombin generation and formation of thrombin-antithrombin III complexes in congenital antithrombin III deficiency.
    Boyer C; Wolf M; Lavergne JM; Larrieu MJ
    Thromb Res; 1980 Oct; 20(2):207-18. PubMed ID: 7209877
    [No Abstract]   [Full Text] [Related]  

  • 2. The effect of plasma antithrombin concentration on thrombin generation and fibrin gel structure.
    Elgue G; Sanchez J; Fatah K; Olsson P; Blombäck B
    Thromb Res; 1994 Jul; 75(2):203-12. PubMed ID: 7974394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New Prothrombin Mutation (Arg596Trp, Prothrombin Padua 2) Associated With Venous Thromboembolism.
    Bulato C; Radu CM; Campello E; Gavasso S; Spiezia L; Tormene D; Simioni P
    Arterioscler Thromb Vasc Biol; 2016 May; 36(5):1022-9. PubMed ID: 27013614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The transient increase of plasma thrombin-antithrombin III (TAT) complex levels in patients with congenital antithrombin III deficiency during antithrombin III administration is due to extraction of thrombin from fibrin.
    Kario K; Matsuo T; Kabayashi H; Matsuo M; Yamamoto K
    Thromb Res; 1991 Aug; 63(4):469-72. PubMed ID: 1755000
    [No Abstract]   [Full Text] [Related]  

  • 5. Crossed immunoelectrophoresis as applied to studies on complex formation. The binding of heparin to antithrombin III and the antithrombin III--thrombin complex.
    Andersson LO; Engman L; Henningsson E
    J Immunol Methods; 1977; 14(3-4):271-81. PubMed ID: 557071
    [TBL] [Abstract][Full Text] [Related]  

  • 6. INACTIVATION OF PURIFIED AUTOPROTHROMBIN I WITH ANTITHROMBIN.
    SEEGERS WH; SCHROEER H; KAGAMI M
    Can J Biochem; 1964 Oct; 42():1425-35. PubMed ID: 14240727
    [No Abstract]   [Full Text] [Related]  

  • 7. CRYOCOAGULOPATHY WITH PRESENCE OF IMMUNOANTITHROMBIN IN THE COURSE OF LUPUS ERYTHEMATOSUS DISSEMINATUS.
    STRUZIK T; HANICKI Z; HAWIGER J; BIERNACKA B
    Acta Med Pol; 1964; 5():61-80. PubMed ID: 14133809
    [No Abstract]   [Full Text] [Related]  

  • 8. A functional abnormal antithrombin III (AT III) deficiency: AT III Charleville.
    Aiach M; Nora M; Fiessinger JN; Roncato M; François D; Gelas MA
    Thromb Res; 1985 Sep; 39(5):559-70. PubMed ID: 4082101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies on an antithrombin. III. A plasma antithrombin test for the prediction of intravascular clotting.
    KAY JH; HUTTON SB; WEISS GN; OCHSNER A
    Surgery; 1950 Jul; 28(1):24-8. PubMed ID: 15442785
    [No Abstract]   [Full Text] [Related]  

  • 10. Abnormal antithrombin III (antithrombin III "Budapest") as a cause of a familial thrombophilia.
    Sas G; Blaskó G; Bánhegyi D; Jákó J; Pálos LA
    Thromb Diath Haemorrh; 1974 Sep; 32(1):105-15. PubMed ID: 4454033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prevention of thrombosis by Hemoclar. Preliminary results of a test in a patient with antithrombin III deficiency].
    Fischer AM; Aurousseau MH; Dautzenberg MD; Bentata-Pessayre M; Beguin S
    Rev Fr Transfus Immunohematol; 1982 Jun; 25(3):265-72. PubMed ID: 6180463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Familial deficiency of antithrombin III: evidence for heterogeneity existing within the family.
    d'Souza S; Ekert H
    Aust N Z J Med; 1984 Dec; 14(6):835-40. PubMed ID: 6598052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacologic modulation of thrombin generation associated with human clots by human purified antithrombin alone or in the presence of low molecular weight heparin or unfractionated heparin.
    Meddahi S; Bara L; Fessi H; Samama MM
    Blood Coagul Fibrinolysis; 2000 Jan; 11(1):51-9. PubMed ID: 10691099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antithrombin III Toyama: a hereditary abnormal antithrombin III of a patient with recurrent thrombophlebitis.
    Sakuragawa N; Takahashi K; Kondo S; Koide T
    Thromb Res; 1983 Jul; 31(2):305-17. PubMed ID: 6636045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Thrombin, antithrombin, thrombin-antithrombin complex (TAT)].
    Sakata T
    Nihon Rinsho; 2004 Dec; 62 Suppl 12():626-8. PubMed ID: 15658407
    [No Abstract]   [Full Text] [Related]  

  • 16. Interaction of complement S-protein with thrombin-antithrombin complexes: a role for the S-protein in haemostasis.
    Jenne D; Hugo F; Bhakdi S
    Thromb Res; 1985 May; 38(4):401-12. PubMed ID: 2409614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prothrombin fragment 1 + 2, thrombin-antithrombin III-complexes and fibrinopeptide A in spontaneously clotting whole blood in vitro. Effects of heparin addition and antithrombin III deficiency.
    Herren T; Straub PW; Haeberli A
    Thromb Haemost; 1994 Jan; 71(1):49-53. PubMed ID: 8165646
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antithrombin III Glasgow: a variant with increased heparin affinity and reduced ability to inactivate thrombin, associated with familial thrombosis.
    Lane DA; Lowe GD; Flynn A; Thompson E; Ireland H; Erdjument H
    Br J Haematol; 1987 Aug; 66(4):523-7. PubMed ID: 3663509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Markers of increased thrombin generation.
    Prisco D
    Ric Clin Lab; 1990; 20(4):217-25. PubMed ID: 2075375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hereditary antithrombin III deficiency. Effect of antithrombin III deficiency on platelet function.
    Carvalho A; Ellman L
    Am J Med; 1976 Aug; 61(2):179-83. PubMed ID: 952292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.